BayWa Restructuring Stalls as Geopolitical Tensions and Renewable Sale Collapse Force a Rethink

BayWa scraps rescue blueprint after failed €1.7B renewables sale; Q1 revenue slumps 36%, shares hit €12.45. Analyst warns of extreme risk despite buy rating.

The restructuring blueprint BayWa hoped would steer it out of deep financial trouble is being torn up and rewritten. A mix of soaring risk from the Middle East conflict and a failed €1.7 billion partial disposal of its renewables arm has forced Chief Restructuring Officer Michael Baur to go back to the drawing board. The market’s verdict was swift: shares fell 6.74% on the day to €12.45, leaving the stock down more than a quarter since the start of 2026.

Revenue Slump but Operating Progress

First-quarter 2026 figures laid bare the scale of the contraction. Group revenue sank to €2.3 billion from €3.6 billion a year earlier, partly due to the sale of the RWA subsidiary but also reflecting a broad market malaise. The renewable energy division — meant to be BayWa’s strategic engine — saw revenue slide 23% to €624.8 million. That segment, now a drag rather than a driver, is at the heart of the crisis.

Yet on an operational level, the picture brightens slightly. CFO Matthias Rapp reported that adjusted EBITDA at the start of the financial year came in above the original restructuring plan and was significantly better than the prior-year period. Management insists liquidity remains solid even as it shrinks the portfolio and pivots to higher-margin products.

€1.7 Billion Sale Falls Through, Debt Target Looms Large

A cornerstone of the original rescue plan was a partial sale of BayWa r.e. that was supposed to raise €1.7 billion. Deteriorating market conditions and the unit’s own weak performance have made that number unattainable. The company is now scrambling to plug the hole. The broader debt reduction target — around €4 billion — underscores just how much financial heavy lifting remains.

Market chatter points to the possibility of a creditor waiver in the region of €1 billion to stabilise the balance sheet. A standstill agreement with BayWa’s lending banks runs until autumn 2026, giving management a tight deadline to produce a credible new plan before negotiations could turn nasty.

Analyst Backing with a Warning

Despite the turmoil, Baader Bank retains a buy recommendation with a price target of €6 — roughly half the current share price. The analyst describes the stock as deeply undervalued but is explicit about the extreme risk. The share price has tumbled 42% from its 52-week high of €21.50, and over the past 30 days it has lost another 15.31%.

Governance Shifts and Reporting Delay

The restructuring turmoil is also rippling through BayWa’s corporate calendar. The annual financial report for 2025 will not be delivered on schedule; the auditor needs the finalised restructuring concept before signing off. The company now targets October 30, 2026, for publication, though it says it will release the report sooner once the revised plan is complete and audited.

Meanwhile, the supervisory board is getting fresh blood. A court has appointed three new expert members — Dr. Ines Kapphan, Solveig Menard-Galli and Christine Rittner-Koch — whose mandates will be confirmed by the annual general meeting. Whether that governance shake-up is enough to restore investor confidence remains an open question as autumn 2026 looms.